Ronald A. Krasnow's Net Worth
$3.29 Million
Who is Ronald A. Krasnow?
Ronald A. Krasnow has an estimated net worth of $3.29 Million. This is based on reported shares across multiple companies, which include Relypsa Inc, and Menlo Therapeutics Inc..
SEC CIK
Ronald A. Krasnow's CIK is 0001591469
Past Insider Trading and Trends
2015 was Ronald A. Krasnow's most active year for acquiring shares with 7 total transactions. Ronald A. Krasnow's most active month to acquire stocks was the month of December. 2015 was Ronald A. Krasnow's most active year for disposing of shares, totalling 13 transactions. Ronald A. Krasnow's most active month to dispose stocks was the month of August. 2015 saw Ronald A. Krasnow paying a total of $221,902.80 for 94,375 shares, this is the most they've acquired in one year. In 2015 Ronald A. Krasnow cashed out on 140,870 shares for a total of $2,899,388.69, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Relypsa Inc No price found
See RemarksRonald A. Krasnow used to own units in Common Stock but no longer holds any shares there.acquired a total of 79,750 shares in Relypsa Inc at a cost of $221,902.80, Ronald also disposed a total of 100,098 shares of Relypsa Inc equalling to $3,507,973.03.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -14.73K |
$32.00 | -$564,672.00 |
0
|
Sep 1
| |||
Form 4
| -6.56% | -1.03K |
$31.89 | -$32,974.26 | 14.73K |
Aug 15
| |||
Form 4
| +6.13% | 910 |
$19.96 | -$10,938.08 | 15.76K |
Jun 3
| |||
Form 4
| +41.75% | 4.38K |
—
|
—
| 14.85K |
Nov 6
| |||
Form 4
| -4.75% | -522.00 |
$24.75 | -$12,921.85 | 10.48K |
Aug 17
| |||
Form 4
| +100.00% | 5.5K |
—
|
—
| 11K |
Aug 10
| |||
Form 4
| -65.30% | -10.35K |
$39.00 | -$403,572.00 | 5.5K |
Scheduled
|
Feb 25 - Feb 27
| ||
Form 4
| -38.69% | -10.00K |
$39.00 | -$390,000.00 | 15.85K |
Scheduled
|
Feb 23 - Feb 24
| ||
Form 4
|
—
|
0
|
$19.39 | -$1,716,897.20 | 25.85K |
Scheduled
|
Jan 21
| ||
Form 4
|
—
|
0
|
$18.17 | -$154,094.84 | 25.85K |
Scheduled
|
Jan 14
| ||
Form 4
| +27.03% | 5.5K |
—
|
—
| 25.85K |
Aug 14
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Menlo Therapeutics Inc. (VYNE) Snapshot price: $1.87
See Remarks
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |